Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB01601_DB08919_nanopub.RARE258ttHVLm1Mvys3eg3KdbkOaaq2pt7pd5jcNzEWd0#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB01601_DB08919 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB01601_DB08919 label "DDI between Lopinavir and Zuclopenthixol acetate - Lopinavir, a strong CYP2D6 inhibitor, may increase the serum concentration of zuclopenthixol by decreasing its metabolism. Consider alternate therapy or monitor for changes in the therapeutic and adverse effects of zuclopenthixol if lopinavir is initiated, discontinued or dose changed. [drugbank_resource:DB01601_DB08919]" assertion.
- drugbank_resource:DB01601_DB08919 identifier "drugbank_resource:DB01601_DB08919" assertion.
- drugbank_resource:DB01601_DB08919 title "DDI between Lopinavir and Zuclopenthixol acetate - Lopinavir, a strong CYP2D6 inhibitor, may increase the serum concentration of zuclopenthixol by decreasing its metabolism. Consider alternate therapy or monitor for changes in the therapeutic and adverse effects of zuclopenthixol if lopinavir is initiated, discontinued or dose changed." assertion.
- drugbank:DB01601 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB01601_DB08919 assertion.
- drugbank:DB08919 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB01601_DB08919 assertion.